Keywords
Diabetes Mellitus
Aspergillus fumigatus
Abstract
Background: Allergic bronchopulmonary aspergillosis is a rare entity, caused by a hypersensitivity reaction of the immune system to Aspergillus fumigatus, characterized by the presence of pulmonary infiltrates, bronchiectasis and increased eosinophils in peripheral blood.
Case report: 42-year-old male with diabetes mellitus, with poor adherence to treatment, went to the emergency room due to rapidly progressive dyspnea and severe hypoxemia, pneumonia and bilateral pleural effusion were evident, laboratory studies reported, HbA1c 9.4%, eosinophils 3650 cells/mL, serum IgE for Aspergillus fumigatus 0.84 IU/mL. Treatment was started with supplemental oxygen, prednisone and itraconazole, to which the patient showed clinical and radiological improvement.
Conclusion: Invasive mycoses have a mortality of 21 to 80%, frequently in immunocompromised patients, they are usually not described in patients with diabetes mellitus; The prevalence of fungal colonization among diabetic patients has been described as 37% compared to 4.7% in non-diabetic patients.
Keywords: Allergic bronchopulmonary aspergillosis; Diabetes mellitus; Aspergillus fumigatus.
References
Fernández de Córdova-Aguirre JC, Velasco-Medina AA, Cariño-Cartagena DA, Velázquez-Sámano G. Allergic Bronchopulmonary Aspergillosis. Rev Alerg México 2014; 61: 121-6. https://doi.org/10.29262/ram.v61i2.34
Salcedo Hernández CJ, Tomalá Salvatierra ÁM, Ramírez Amaya JE, Arteaga Muñoz JL. Aspergilosis y su impacto en la función pulmonar. Reciamuc 2022; 6 (4): 88-97. https://doi.org/10.26820/reciamuc/6.(4).octubre.2022.88-97
Suzuki Y, Suda T. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management. Allergol Int 2019; 68 (4): 413-419. https://doi.org/10.1016/j.alit.2019.05.006
Pahal P, Penmetsa GK, Modi P, Sharma S. Eosinophilic Pneumonia. In: StatPearls Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK537169/
Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, et al. Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Pública Mex 2023; 65 (1): s163-8. https://www.saludpublica.mx/index.php/spm/article/view/14832
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Reviews 2020; 16 (5): 442-449. 10.2174/1573399815666191024085838
Hernández-Solís A, Camerino Guerrero A, Colín Muñoz Y, et al. [Pulmonary mycosis in patients with diabetes mellitus. Clinical characteristics and risk factors]. Rev Iberoamer Micol 2020; 37 (2): 53-57. doi: https://doi.org/10.1016/j.riam.2020.04.002
Fernández-Trujillo L, Eraso I, Morales EI, Sua LF. Invasive Aspergillosis in a Patient With Diabetes Mellitus as the Only Risk Factor: Case Report and Literature Review. J Investig Med High Impact Case Rep 2023; 11: 23247096231175443. https://doi.org/10.1177/232470962311754
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2024 Revista Alergia México